- Chief Executive Officer, President and Director Current · dates not published
Skip to record
Executive record
Najat Khan, Ph.D.
Chief Executive Officer, President and Director at RECURSION PHARMACEUTICALS, INC.
Follow record
More
Alpha ID: alpha:person:najat-khan-ph-dVersion: public-0As of: 2026-10-05
Not yet claimed4 published Claims2 sources
- Executive
- Director
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
- Professional RoleChief Executive Officer, President and Director at RECURSION PHARMACEUTICALS, INC.www.sec.gov
- Board membershipServes on the board of RECURSION PHARMACEUTICALS, INC.www.sec.gov
- Professional RoleChief Executive Officer and President at RECURSION PHARMACEUTICALS, INC.www.sec.gov
- Executive titleExecutive title: Chief Executive Officer and Presidentwww.sec.gov
Board service
Boards
Claims
Executive career
- Current · dates not publishedChief Executive Officer and President · RECURSION PHARMACEUTICALS, INC.
- Dates not publishedExecutive title: Chief Executive Officer and President · Organization not published
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Open source
sec def 14a · Source published: Apr 30, 2026 · Retrieved: Sep 12, 2026
Supports 3 claims
- Professional Role: Chief Executive Officer and President at RECURSION PHARMACEUTICALS, INC. · Claim reviewed: Sep 12, 2026
- Professional Role: Chief Executive Officer, President and Director at RECURSION PHARMACEUTICALS, INC. · Claim reviewed: Sep 12, 2026
- Executive title: Executive title: Chief Executive Officer and President · Claim reviewed: Sep 12, 2026
Open source
public source · Source published: Date unavailable · Retrieved: Date unavailable
Supports 1 claim
- Board membership: Serves on the board of RECURSION PHARMACEUTICALS, INC. · Claim reviewed: Sep 12, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-05
- Biography
- not observed
- Board service
- published
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope